Land: Australien
Sprache: Englisch
Quelle: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CARPROFEN
ZOETIS AUSTRALIA PTY LTD
carprofen(75mg/Tb)
ORAL TABLET
CARPROFEN ANTI-INFLAMMATORY-NONSTEROIDAL Active 75.0 mg/Tb
14 Tablets; 60 Tablets
VM - Veterinary Medicine
ZOETIS AUSTRALIA
DOG | BITCH | CASTRATE | PUPPY
MUSCULOSKELETAL SYSTEM
ANTI-INFLAMMATORY AGENT | ANTIPYRETIC | BONE SORENESS | BRUISING | BURSITIS | INFLAMMATORY RHEUMATIC ARTHRIT | JOINT DISEASE | LIGAMENT SPRAINS | MUSCLE SORENESS | OSTEOARTHRITIS | PLATELET ACTIVITY | RHEUMATISM | SPRAINS | STRAINS | TENDON SPRAINS | TRAUMATIC SWELLING
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [ANTI-INFLAMMATORY AGENT]; A non-steroidal anti-inflammatory drug for the relief of pain and inflammation in dogs.Should NOT be used in dogs exhibiting hypersensitivity to carprofen. Use of this product in cats is contraindicated.
Registered
2023-07-01
BATCH EXP Each tablet contains 75 MG CARPROFEN A non-steroidal anti-inflammatory drug for the relief of pain and inflammation in dogs 14 CHEWABLE TABLETS 75 MG P 0 01 0 3 - L - 0 0 0 Pfizer Animal Health A division of Pfizer Australia Pty Ltd. Wharf Rd, West Ryde. 2114 ® Pfizer trademark © 2008 Made in USA READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. DIRECTIONS FOR USE: DOSAGE: 2–4 mg/kg bodyweight per day. Dose, frequency and duration of treatment will be dependent upon clinical response. See leaflet for full details. APVMA: 52469/14/0508 LA3118B 8547051 STORAGE: Store below 25°C (Air Conditioning) in a dry place out of direct sunlight. ® PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Code No. MH/DRUGS/PD/149 CHEWABLE TABLETS FOR DOGS File Name: 52469_44705_14 tabs_Primary_MPL_V01.pdf Dimension: 31mm x 95mm Date: V01, 0508 Scale: 100% A4 APPROVED LABEL Info PEST Verified BATCH EXP Pfizer Animal Health A division of Pfizer Australia Pty Ltd. Wharf Rd, West Ryde. 2114 ® Pfizer trademark © 2008 READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. DIRECTIONS FOR USE: DOSAGE: 2–4 mg/kg bodyweight per day. Dose, frequency and duration of treatment will be dependent upon clinical response. See leaflet for full details. STORAGE: Store below 25°C (Air Conditioning) in a dry place out of direct sunlight. APVMA: 52469/60/0508 LA3119B 8503051 Each tablet contains 75 MG CARPROFEN A non-steroidal anti-inflammatory drug for the relief of pain and inflammation in dogs 60 CHEWABLE TABLETS 75 MG PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Made in USA P 00 1 04 - L - 0 0 0 ® Code No. MH/DRUGS/PD/149 CHEWABLE TABLETS FOR DOGS File Name: 52469_44705_60 tabs_Primary_MPL_V01.pdf Dimension: 69mm x 107mm Date: V01, 0508 Scale: 100% A4 APPROVED LABEL RIMADYL ® 25 MG CHEWABLE TABLETS FOR DOGS RIMADYL ® 75 MG CHEWABLE TABLETS FOR DOGS RIMADYL ® 100 MG CHEWABLE TABLETS FOR DOGS Rimadyl Chewable Tablets are light brown tablets with a bisect on Lesen Sie das vollständige Dokument
PRODUCT NAME: RIMADYL CHEWABLE TABLETS PAGE: 1 OF 4 THIS REVISION ISSUED: AUGUST, 2011 MATERIAL SAFETY DATA SHEET Issued by: Pfizer Australia Pty Ltd Phone: 1800 814 883 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) - IDENTIFICATION OF THE MATERIAL AND SUPPLIER Pfizer Australia Pty Ltd 38-42 Wharf Road West Ryde NSW 2114 Tel: 1800 814 883 Fax: (02) 9850 3399 ____________________________________ PFIZER AUSTRALIA PTY LTD A.B.N. 50 008 422 348 CHEMICAL NATURE: Carprofen is a non-steroidal anti-inflammatory ingredient. TRADE NAME: RIMADYL CHEWABLE TABLETS PRODUCT USE: Analgesia and relief of chronic inflammation in joint diseases in dogs. CREATION DATE: SEPTEMBER, 2006 THIS VERSION ISSUED: AUGUST, 2011 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S45. In case of accident or if you feel unwell, contact a doctor or Poisons Information Centre immediately (show the label where possible). SUSMP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : Light brown tablets. ODOUR: Characteristic odour. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. P P P O O O T T T E E E N N N T T T I I I A A A L L L H H H E E E A A A L L L T T T H H H E E E F F F F F F E E E C C C T T T S S S INHALATION: SHORT TERM EXPOSURE: Long term inhalation of high amounts of any nuisance dust may overload lung clearance mechanism. Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. LONG TERM EXPOSURE: No Lesen Sie das vollständige Dokument